Serum levels of soluble interleukin-2 receptor after bone marrow transplantation: A true marker of acute graft-versus-host disease

Leukemia and Lymphoma

Volumn 38, Issue 5-6, 2000, Pages 533-540

  Kami, Masahiro ^a   Matsumura, Tomoko ^b   Tanaka, Yuji ^c   Mikami, Yasuyo ^c   Miyakoshi, Shigesaburo ^a   Ueyama, Jun Ichi ^a   Morinaga, Shin Ichi ^a   Mori, Shin Ichiro ^b   Machida, Utako ^c   Kanda, Yoshinobu ^c   Chiba, Shigeru ^c   Sakamaki, Hisashi ^b   Hirai, Hisamaru ^c   Muto, Yoshitomo ^a  

^a TORANOMON HOSPITAL   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Acute graft versus host disease; Allogeneic bone marrow transplantation; Autologous peripheral blood stern cell transplantation; Engraftment; Soluble interleukin 2 receptor

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; BONE MARROW TRANSPLANTATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE; DISEASE COURSE; DISEASE MARKER; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0033866728     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009059272     Document Type: Article

References (26)

1. Ferrara J.L. (1995) Cytokine inhibitors and graft-versus-host disease. Ann N Y Acad Sci, 770, 227-36.
2. Antin J.H. & Ferrara J.L. (1992) Cytokine dysregulation and acute graft-versus-host disease. Blood, 80, 2964-8.
3. Tanaka J., Imamura M., Kasai M., Hashino S., Kobayashi S., Noto S., Sakurada K. & Asaka M. (1996) Cytokine network in peripheral blood mononuclear cells after allogeneic bone marrow transplantation. Transplant Proc, 28, 1746-7.
4. Tanaka J., Imamura M., Kasai M., Masauzi N., Matsuura A., Ohizumi H., Morii K., Kiyama Y., Naohara T., Saitho M. & et al. (1993) Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol, 85, 558-65.
5. Roy J., Blazar B.R., Ochs L. & Weisdorf D.J. (1995) The tissue expression of cytokines in human acute cutaneous graft-versus-host disease. Transplantation, 60, 343-8.
6. Ochs L.A., Blazar B.R., Roy J., Rest E.B. & Weisdorf D.J. (1996) Cytokine expression in human cutaneous chronic graft-versus-host disease. Bone Marrow Transplant, 17, 1085-92.
7. Tong J., Viale M., Bacigalupo A., Podesta M., Sogno G., Tedone E. & Marmont A.M. (1992) Cytokine serum levels and acute graft versus host disease after allogeneic bone marrow transplantation. Haematologica, 77, 365-6.
8. Barak V., Levi-Schaffer F., Nisman B. & Nagler A. (1995) Cytokine dysregulation in chronic graft versus host disease. Leuk Lymphoma, 17, 169-73.
9. Symons J.A., Wood N.C., Di Giovine F.S. & Duff G.W. (1988) Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol, 141, 2612-8.
10. Josimovic-Alasevic O., Feldmeier H., Zwingenberger K., Harms G., Hahn H., Shrisuphanunt M. & Diamantstein T. (1988) Interleukin 2 receptor in patients with localized and systemic parasitic diseases. Clin Exp Immunol, 72, 249-54.
11. Engelhard D., Nagler A., Singer R. & Barak V. (1994) Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after T-lymphocyte depleted bone marrow transplantation for hematological neoplasias. Leuk Lymphoma, 12, 273-80.
12. Remberger M. & Ringden O. (1995) Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation. Transplantation, 60, 1293-9.
13. Siegert W., Josimovic-Alasevic O., Schwerdtteger R., Baurmann H., Schmidt C.A., Musch R., Schmid H.J., Hartmann R., Henze G., Huhn D. & et al. (1990) Soluble interleukin 2 receptors in patients after bone marrow transplantation. Bone Marrow Transplant, 6, 97-101.
14. Miyamoto T., Akashi K., Hayashi S., Gondo H., Murakawa M., Tanimoto K., Harada M. & Niho Y. (1996) Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease. Bone Marrow Transplant, 17, 185-90.
15. Liem L.M., van Houwelingen H.C. & Goulmy E. (1998) Serum cytokine levels after HLA-identical bone marrow transplantation. Transplantation, 66, 863-71.
16. Kobayashi S., Imamura M., Hashino S., Tanaka J. & Asaka M. (1997) Clinical relevance of serum soluble interleukin-2 receptor levels in acute and chronic graft-versus-host disease. Leuk Lymphoma, 28, 159-69.
17. Petersen F.B., Buckner C.D., Appelbaum F.R., Sanders J.E., Bensinger W.I., Storb R., Deeg H.J., Witherspoon R.P., Sullivan K.M., Clift R.A. & et al. (1992) Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. Bone Marrow Transplant, 10, 83-8.
18. Spitzer T.R., Cottler-Fox M., Torrisi J., Cahill R., Greenspan A., Lynch M. & Deeg H.J. (1989) Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation. Bone Marrow Transplant, 4, 559-65.
19. Riddell S., Appelbaum F.R., Buckner C.D., Stewart P., Clift R., Sanders J., Storb R., Sullivan K. & Thomas E.D. (1988) High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia. J Clin Oncol, 6, 576-82.
20. Ratanatharathorn V., Karanes C., Uberti J., Lum L.G., de Planque M.M., Schultz K.R., Cronin S., Dan M.E., Mohamed A., Hussein M. & et al. (1993) Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes. Blood, 81, 2194-9.
21. Takahashi S., Okamoto S.I., Shirafuji N., Ikebuchi K., Tani K., Shimane M., Matsudaira T., Irie S., Tsuruta T., Matsuishi E. & et al. (1994) Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia. Bone Marrow Transplant, 13, 239-45.
22. Glucksberg H., Storb R., Fefer A., Buckner C.D., Neiman P.E., Clift R.A., Lerner K.G. & Thomas E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation, 18, 295-304.
23. McDonald G.B., Sharma P., Matthews D.E., Shulman H.M. & Thomas E.D. (1984) Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology, 4, 116-22.
24. Foley R., Couban S., Walker I., Greene K., Chen C.S., Messner H. & Gauldie J. (1998) Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation. Bone Marrow Transplant, 21, 769-73.
25. Grimm J., Zeller W. & Zander A.R. (1998) Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for GVHD. Bone Marrow Transplant, 21, 29-32.
26. Jadus M.R. & Wepsic H.T. (1992) The role of cytokines in graft-versus-host reactions and disease. Bone Marrow Transplant, 10, 1-14.